Streetbeat News

Products Services

AUUD

LGVN

UCAR

Auddia Inc. (AUUD) shares surged 139% following the USPTO's award of U.S. Patent 11,935,520 for its AI technology in the faidr app, enabling ad-free AM/FM radio for subscribers. U Power (UCAR) shares rose 113% as it announced its battery-swapping model for electric vehicles is set for commercial rollout in Wuhu, China. Longeveron (LGVN) shares increased 119% after issuing a letter to shareholders outlining its corporate strategy and goals for 2024.

Portfolio Pulse from ryanfaloona@benzinga.com

April 08, 2024 | 12:44 pm

ECOR

electroCore, Inc. has announced the launch of Truvaga Plus, a new product aimed at enhancing general wellness. This development could potentially open new market segments for the company and drive revenue growth.

Portfolio Pulse from Benzinga Newsdesk

April 08, 2024 | 12:44 pm

MULN

Mullen Automotive, Inc. (MULN) announces significant cost reduction and consolidation measures expected to save approximately $170 million over the next 12 months. The company is focusing on the commercial EV segment, aiming to sell 100 units in April, as part of its strategy to align with current market conditions and drive near-term revenue. These actions include prioritizing commercial programs, integrating engineering centers, and expanding the dealer network, aiming for long-term growth and improved financial results.

Portfolio Pulse from Benzinga Newsdesk

April 08, 2024 | 12:43 pm

MTEK

Maris-Tech announced receiving an order worth approximately $110,000 from an existing customer in the defense industry for a novel miniature intelligence-gathering product based on the Mars platform technology.

Portfolio Pulse from Benzinga Newsdesk

April 08, 2024 | 12:42 pm

KULR

KULR Technology Group has been awarded a contract to supply Safecases to an eVTOL company, focusing on thermal runaway characterization for eVTOL aircraft batteries. This collaboration is expected to lead to more product and design opportunities, aiming for recurring revenue and addressing battery safety and management challenges.

Portfolio Pulse from Benzinga Newsdesk

April 08, 2024 | 12:41 pm

NVCT

Nuvectis Pharma, Inc. (NASDAQ:NVCT) announced positive results from the AACR conference for NXP900, showing synergistic activity with osimertinib (Tagrisso) and alectinib (Alecensa) in treating non-small cell lung cancer (NSCLC) resistant cells. The study confirms previous data from Astra Zeneca and highlights NXP900's potential in overcoming resistance to current NSCLC treatments. The Phase 1a dose escalation study of NXP900 is progressing as planned.

Portfolio Pulse from Benzinga Newsdesk

April 08, 2024 | 12:41 pm

CAUD

Collective Audience (CAUD) shares are trading higher following the announcement of its acquisition of DSL Digital. This acquisition will enable Collective Audience to launch AI-powered AudienceServices, expanding its capabilities and offerings in the digital services sector.

Portfolio Pulse from Benzinga Newsdesk

April 08, 2024 | 12:41 pm

CRMD

CorMedix Inc. (NASDAQ:CRMD) has signed a 5-year supply contract with ARC Dialysis, LLC for DefenCath®, a product recently approved by the FDA for preventing infections in hemodialysis patients. This partnership aligns with CorMedix's strategy to establish long-term relationships with innovative dialysis providers. DefenCath®'s commercialization is set to begin on April 15th, following its approval under the LPAD on November 15, 2023. ARC Dialysis, known for its commitment to patient care and innovation, operates in approximately 100 inpatient and 18 outpatient facilities in Florida.

Portfolio Pulse from Benzinga Newsdesk

April 08, 2024 | 12:41 pm

BTCUSD

XRPUSD

Ripple CEO Brad Garlinghouse predicts the cryptocurrency market cap could reach $5 trillion by 2024, driven by the launch of U.S. spot Bitcoin ETFs and the upcoming Bitcoin halving event. These developments, along with increased institutional investment, are expected to significantly impact the market dynamics. The first U.S. spot Bitcoin ETFs were approved on Jan. 10, and the Bitcoin halving event is set to occur later this month.

Portfolio Pulse from Murtuza Merchant

April 08, 2024 | 12:40 pm

JAGX

Jaguar Health, Inc. has been granted an extension until August 13, 2024, by Nasdaq to meet the $1.00 bid price requirement for continued listing. The company is also awaiting top line results from its Phase 3 OnTarget trial of crofelemer for the preventative treatment of cancer therapy-related diarrhea.

Portfolio Pulse from Benzinga Newsdesk

April 08, 2024 | 12:40 pm